Article
Personalized medicine in sarcoidosis: predict responders and nonresponders.
Current opinion in pulmonary medicine - 1 Sept 2015
Petrek Martin
Abstract excerpt
PURPOSE OF REVIEW: Treatment of sarcoidosis, a granulomatous disease affecting multiple organs with predominance to the lung, is complicated by variable response of individual patients to treatment options ranging from corticosteroids to second-line steroid-sparing agents and further to biologicals. This is partially because of varying disease manifestation, but polymorphic genes affecting drug metabolization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
